Track the 휴온스 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 휴온스 has recorded 1 insider filings. Market capitalisation: €297.7bn. The latest transaction was disclosed on 25 March 2026 (Sale). Among the most active insiders: 휴온스글로벌. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
휴온스 is a company in the health and pharmaceutical sector, listed on the XKRX market. It focuses on the development of innovative pharmaceutical products and health solutions.